MB Rahastot invests in Spider Med Oy, a rapidly growing Finnish oral health care company, to support its expansion and innovative service delivery models.
Information on the Target
Spider Med Oy, founded in 2020, is a prominent Finnish company specializing in oral health care. It has rapidly established itself as a key partner for both public and private sector stakeholders in the industry. Utilizing innovative and effective operational models, Spider Med delivers its services on a national scale and currently employs over 450 dental professionals.
The founders, Joona Iso-Lotila, Arttu Rissanen, and Pinja Pesonen, remain integral to the company, overseeing its development as significant stakeholders. They are committed to enhancing Spider Med's brand and expanding its offerings to oral health professionals, underlining their dedication to quality and impactful dental care.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Finland
Finland's oral health care industry has seen substantial growth, driven by an increasing demand for dental services from both private individuals and public healt
Similar Deals
Verso Capital and Armada Credit Partners → Suomen Avustajapalvelut
2025
Voima Ventures → Sooma Medical
2024
EW Healthcare Partners → Grundium Oy
2023
Verso Capital → Vetrospace
2023
Juuri Partners → Mediconsult Oy
2023
Nordic Secondary Fund II → Pixieray Oy
2023
MB Rahastot
invested in
Spider Med Oy
in 2023
in a Growth Equity & Expansion Capital deal